TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin
- 1 July 1995
- Vol. 82 (1), 121-130
- https://doi.org/10.1016/0092-8674(95)90058-6
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Phospholipid signalingCell, 1995
- A mammalian protein targeted by G1-arresting rapamycin–receptor complexNature, 1994
- TOR1 and TOR2 are structurally and functionally similar but not identical phosphatidylinositol kinase homologues in yeast.Molecular Biology of the Cell, 1994
- Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2Cell, 1993
- Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity.Molecular and Cellular Biology, 1993
- Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progressionCell, 1993
- Antifungal properties of the immunosuppressant FK-506: identification of an FK-506-responsive yeast gene distinct from FKB1.Molecular and Cellular Biology, 1991
- Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in YeastScience, 1991
- Mutations in the autoinhibitor site of the regulatory subunit of cAMP-dependent protein kinase I. Replacement of Ala-97 and Ser-99 interferes with reassociation with the catalytic subunitJournal of Biological Chemistry, 1991
- Phosphoinositide kinasesBiochemistry, 1990